New Delhi: Sputnik Light, the single-dose Covid-19 vaccine, can submit Russian safety data for approval in India, Dr Reddy’s Laboratories said.
“After detailed deliberation, the committee recommended that the firm should present the safety, immunogenicity and efficacy data of the phase 3 clinical trial of Sputnik Light that is being carried out in Russia for considering the proposal for grant of marketing authorization in the country,” stated the Subject Expert Committee (SEC) looking into DRL’s proposal on Wednesday. Sputnik Light is essentially the first dose of Sputnik V, which was developed by the Gamaleya Research Institute of Epidemiology and Microbiology in Moscow.
Sputnik Light is a single dose Covid-19 vaccine from the makers of Sputnik V and is yet to be approved in India.
Comments are closed.